Concordance between Gleason scores of needle biopsies and radical prostatectomy specimens: a population-based study
- PMID: 19154461
- DOI: 10.1111/j.1464-410X.2008.08255.x
Concordance between Gleason scores of needle biopsies and radical prostatectomy specimens: a population-based study
Abstract
Objective: To study the concordance between the Gleason scores of needle biopsies and radical prostatectomy (RP) specimens in a population-based registry, to clarify whether the concordance depends on the annual number of RP specimens assessed in the pathology unit, and to identify preoperative clinical factors that predict upgrading from a Gleason score of <or=6 in the biopsy to >or=7 in the RP specimen.
Patients and methods: Through the Cancer Registry of Norway, we identified 1116 patients with available Gleason scores from biopsy and RP specimens. Concordance was evaluated using the kappa coefficient, and predictors of concordance were assessed in univariate and multivariate logistic regression analyses.
Results: The Gleason scores were identical in biopsy and RP specimens in 591 of the 1116 (53%) patients. The biopsy-based Gleason score more often under-graded (38%) than over-graded (9%) the RP-based Gleason score. Pathology units that examined >40 RP specimens annually had a higher concordance between the Gleason score in the biopsy and RP specimen than did lower-volume units. The rate of upgrading from a Gleason score of <or=6 in the biopsy to >or=7 in the RP specimen increased with increasing preoperative prostate-specific antigen serum levels, and with increasing intervals between biopsy and RP.
Conclusions: The concordance in Gleason score between biopsy and RP was highest among the pathology departments that regularly evaluated RP specimens. Careful consideration of clinical factors and biopsy grading might improve the identification of patients considered as suitable for active surveillance.
Similar articles
-
Increasing the number of biopsies increases the concordance of Gleason scores of needle biopsies and prostatectomy specimens.Urol Oncol. 2007 Sep-Oct;25(5):376-82. doi: 10.1016/j.urolonc.2006.08.028. Urol Oncol. 2007. PMID: 17826653
-
Improved accuracy for predicting the Gleason score of prostate cancer by increasing the number of transrectal biopsy cores.Urol Int. 2007;79(4):302-6. doi: 10.1159/000109713. Urol Int. 2007. PMID: 18025846
-
Usefulness of the 2005 International Society of Urologic Pathology Gleason grading system in prostate biopsy and radical prostatectomy specimens.BJU Int. 2009 May;103(9):1190-4. doi: 10.1111/j.1464-410X.2008.08197.x. Epub 2008 Dec 8. BJU Int. 2009. PMID: 19076142
-
The impact of the 2005 international society of urological pathology consensus conference on standard Gleason grading of prostatic carcinoma in needle biopsies.J Urol. 2008 Aug;180(2):548-52; discussion 552-3. doi: 10.1016/j.juro.2008.04.018. Epub 2008 Jun 11. J Urol. 2008. PMID: 18550106
-
Gleason grading of prostate cancer in needle biopsies or radical prostatectomy specimens: contemporary approach, current clinical significance and sources of pathology discrepancies.BJU Int. 2005 Jun;95(8):1146-52. doi: 10.1111/j.1464-410X.2005.05540.x. BJU Int. 2005. PMID: 15877724 Review.
Cited by
-
Reduction of MRI-targeted biopsies in men with low-risk prostate cancer on active surveillance by stratifying to PI-RADS and PSA-density, with different thresholds for significant disease.Transl Androl Urol. 2018 Feb;7(1):132-144. doi: 10.21037/tau.2017.12.29. Transl Androl Urol. 2018. PMID: 29594027 Free PMC article.
-
Gleason group concordance between biopsy and radical prostatectomy specimens: A cohort study from Prostate Cancer Outcome Registry - Victoria.Prostate Int. 2016 Dec;4(4):145-151. doi: 10.1016/j.prnil.2016.07.004. Epub 2016 Aug 3. Prostate Int. 2016. PMID: 27995114 Free PMC article.
-
Predicting prostate cancer specific-mortality with artificial intelligence-based Gleason grading.Commun Med (Lond). 2021 Jun 30;1:10. doi: 10.1038/s43856-021-00005-3. eCollection 2021. Commun Med (Lond). 2021. PMID: 35602201 Free PMC article.
-
Prostate cancer: predicting tumor aggressiveness using DWI-guided biopsy.Nat Rev Urol. 2011 Oct 25;8(12):652-4. doi: 10.1038/nrurol.2011.163. Nat Rev Urol. 2011. PMID: 22025170 No abstract available.
-
Targeted prostate biopsy using a cognitive fusion of multiparametric magnetic resonance imaging and transrectal ultrasound in patients with previously negative systematic biopsies and non-suspicious digital rectal exam.Croat Med J. 2020 Feb 29;61(1):49-54. doi: 10.3325/cmj.2020.61.49. Croat Med J. 2020. PMID: 32118378 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical